Search by Drug Name or NDC

    NDC 68462-0687-14 tacrolimus 5 mg/1 Details

    tacrolimus 5 mg/1

    tacrolimus is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is TACROLIMUS.

    Product Information

    NDC 68462-0687
    Product ID 68462-687_222e5e02-7296-4d3f-adf7-4d412eee7957
    Associated GPIs 99404080000120
    GCN Sequence Number 021797
    GCN Sequence Number Description tacrolimus CAPSULE 5 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 28492
    HICL Sequence Number 020974
    HICL Sequence Number Description TACROLIMUS
    Brand/Generic Generic
    Proprietary Name tacrolimus
    Proprietary Name Suffix n/a
    Non-Proprietary Name tacrolimus
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name TACROLIMUS
    Labeler Name Glenmark Pharmaceuticals Inc., USA
    Pharmaceutical Class Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206662
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0687-14 (68462068714)

    NDC Package Code 68462-687-14
    Billing NDC 68462068714
    Package 10 BLISTER PACK in 1 CARTON (68462-687-14) / 10 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2020-11-10
    NDC Exclude Flag N
    Pricing Information N/A